company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,52279000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,15113000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,42163000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12826000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1624000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1026000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4916000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,129947000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1878000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,4562000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9217000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13779000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,,totalassets,Total Assets,=,debit,usd,145604000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,19522000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4175000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18538000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4494000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,46729000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,45583000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7694000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3783000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,57060000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,103789000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,59509000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-37558000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,19864000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,41815000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,41815000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,41815000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q2,,2011-06-30,2011-08-05 13:47:53+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,145604000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55267000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,15113000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,30718000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,13476000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1663000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,6328000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,122565000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1756000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1248000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,5974000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9046000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2229000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,18497000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,,totalassets,Total Assets,=,debit,usd,142818000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,20538000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6254000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18533000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2642000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1668000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49635000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,46158000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7283000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3766000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,57207000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,106842000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,59918000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-41636000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-149000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,17843000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35976000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35976000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,35976000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2011.0,Q3,,2011-09-30,2011-11-09 12:45:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,142818000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55504000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,15113000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,19666000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,12522000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1799000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,118000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4639000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,109361000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1561000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,8146000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1698000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,27134000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2216000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,39194000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,,totalassets,Total Assets,=,debit,usd,150116000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,19700000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5638000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7167000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6558000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,2811000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,41874000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,39777000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6887000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,23012000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2649000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,72325000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,114199000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,61222000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-40864000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-700000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,16259000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35917000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35917000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,35917000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q1,,2012-03-31,2012-05-10 16:20:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,150116000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61691000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,15113000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9685000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,13060000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1563000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,34000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3965000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,105111000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1653000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7903000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1653000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6522000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2096000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,18174000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,,totalassets,Total Assets,=,debit,usd,124938000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,20100000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5345000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9228000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3793000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,18000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,38484000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,40328000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6722000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1768000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2007000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,50825000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,89309000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,61755000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-41683000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-700000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,16257000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35629000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35629000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,35629000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q2,,2012-06-30,2012-08-09 15:50:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,124938000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,57246000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,15113000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,6229000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15152000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2611000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,33000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3989000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,100373000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1563000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7660000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1728000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6259000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,3548000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,19195000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,,totalassets,Total Assets,=,debit,usd,121131000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,20300000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3455000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8800000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3841000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,51000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36447000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,40883000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7101000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,5125000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2211000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,55320000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,91767000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,62142000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-47632000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-1256000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,16110000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,29364000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,29364000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,29364000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2012.0,Q3,,2012-09-30,2012-11-09 15:42:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,121131000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,48643000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,26113000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,5142000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,13684000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,3958000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2694000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,693000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,673000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,101600000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1502000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,13614000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7171000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1391000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5754000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2319000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,30249000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,,totalassets,Total Assets,=,debit,usd,133351000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,28729000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9256000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7845000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,941000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1027000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1458000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49256000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,33722000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6722000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2438000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1210000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,44092000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,93348000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,63358000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-37245000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2313000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,16203000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,40003000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,40003000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,40003000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q1,,2013-03-31,2013-05-10 16:51:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,133351000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,47288000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,26130000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,8420000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15617000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,4872000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3879000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1228000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,673000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,108107000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1384000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,9309000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,6927000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1750000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5541000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2330000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,25857000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,,totalassets,Total Assets,=,debit,usd,135348000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,27940000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5653000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6429000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1271000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,4941000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,783000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,47017000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,29786000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6522000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2416000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1227000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,39951000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,86968000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,65821000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-31126000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2313000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15998000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,48380000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,48380000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,48380000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q2,,2013-06-30,2013-08-09 16:15:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,135348000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39911000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,26141000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,15263000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,16289000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,261000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3835000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,3286000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,673000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,105659000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1278000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,7259000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,6686000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1162000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5246000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2430000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,22783000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,,totalassets,Total Assets,=,debit,usd,129720000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,28114000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2934000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6211000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1148000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1286000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39693000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,29812000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,6490000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2632000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1296000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,40230000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,79923000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,66181000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-29834000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2313000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15763000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,49797000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,49797000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,49797000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2013.0,Q3,,2013-09-30,2013-11-08 11:34:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,129720000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,56142000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,26115000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,15534000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,17944000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,455000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3618000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,2148000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,673000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,122629000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1084000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,5716000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,6194000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1314000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4827000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2481000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,20532000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,,totalassets,Total Assets,=,debit,usd,144245000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,27348000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5988000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6004000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1617000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,694000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1922000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,43573000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,25819000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5998000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1853000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1596000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,35266000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,78839000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,78795000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-27006000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2313000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15490000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,440000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,65406000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,65406000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,65406000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q1,,2014-03-31,2014-05-09 15:14:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,144245000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,53532000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,26129000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,14017000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,18646000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,423000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3396000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1988000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1218000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,119349000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,979000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,7460000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,5949000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1275000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4756000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2471000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,21911000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,,totalassets,Total Assets,=,debit,usd,142239000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,27790000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5623000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6264000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1794000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,35000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1013000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,42519000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,21741000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5824000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1223000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1559000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,30347000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,72866000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,80819000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-24494000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2313000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15361000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,69373000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,69373000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,69373000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q2,,2014-06-30,2014-08-06 17:27:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,142239000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,56087000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,26114000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,8857000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,25266000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,133000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3550000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4055000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,124062000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,882000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,13046000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,157000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,1436000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2722000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2313000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,19674000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,,totalassets,Total Assets,=,debit,usd,144618000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,26342000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5924000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7160000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2047000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2436000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,43909000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5457000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,343000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,23253000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,29053000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,72962000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,81340000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-23014000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2313000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15643000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,71656000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,71656000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,71656000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2014.0,Q3,,2014-09-30,2014-11-07 07:30:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,144618000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,59639000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,213000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,33232000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23899000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,328000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2865000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,382000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,295000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,120853000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,634000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,23410000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,146000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,612000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1872000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2282000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,28322000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,,totalassets,Total Assets,=,debit,usd,149809000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,8240000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1411000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9658000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1771000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1847000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7771000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30698000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17578000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4889000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,654000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1957000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25078000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,55776000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,88792000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-7324000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2313000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,14427000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,93582000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,94033000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,94033000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q1,,2015-03-31,2015-05-06 16:20:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,149809000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,71343000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,213000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,37153000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,24338000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,308000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2804000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,259000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,295000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,136713000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,526000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,16655000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,141000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,2065000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1801000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2356000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,23018000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,,totalassets,Total Assets,=,debit,usd,160257000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,8411000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3910000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8660000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1728000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,2279000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7853000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32841000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,13330000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4801000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,436000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2125000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,20692000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,53533000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,92238000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,2252000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2313000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,14096000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,106273000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,106724000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,106724000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q2,,2015-06-30,2015-08-05 14:05:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,160257000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,91505000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,38022000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,26010000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,296000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3686000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1927000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,161446000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2296000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,5124000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,136000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,3136000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1634000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,10030000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,,totalassets,Total Assets,=,debit,usd,173772000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,8411000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4936000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10151000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1152000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,691000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,8133000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,33474000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,13330000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4586000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,210000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4384000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,22510000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,55984000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,95749000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,9488000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2313000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,14411000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,117335000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,117788000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,117788000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2015.0,Q3,,2015-09-30,2015-11-04 16:04:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,173772000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,127981000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,26916000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,36911000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,21570000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,24324000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,237702000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6340000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,5118000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,71839000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,146575000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2170000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,225702000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,,totalassets,Total Assets,=,debit,usd,469744000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,21679000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6166000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13298000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,6274000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,8218000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,55635000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,202410000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,937000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,68570000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,18428000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,290345000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,345980000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,105133000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,14750000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-46269000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,49692000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,123306000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,123764000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,123764000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q2,,2016-06-30,2016-08-03 16:06:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,469744000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,128465000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,25213000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,41455000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,24202000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18146000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,237481000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6563000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,5182000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,73022000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,134886000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2430000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,215520000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,,totalassets,Total Assets,=,debit,usd,459564000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,21730000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7869000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14380000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,16587000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,6243000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,66809000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,196984000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,913000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,41757000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,8291000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,247945000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,314754000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,113440000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,22842000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-46269000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,54339000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,458000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,144810000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,144810000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,144810000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2016.0,Q3,,2016-09-30,2016-11-09 16:02:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,459564000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,243480000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,213000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,38963000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,22978000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,16725000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,322359000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6197000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,5556000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,73022000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,121381000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,688000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,200647000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,,totalassets,Total Assets,=,debit,usd,529203000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8006000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17096000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,834000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,3477000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2876000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,2538000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34827000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1572000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,18375000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,300121000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,320068000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,354895000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,123984000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,41678000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-46269000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,54451000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,173844000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,173844000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,173844000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q1,,2017-03-31,2017-05-03 17:13:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,529203000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,84734000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,213000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,40364000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,23098000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,16726000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,165135000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5880000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,5619000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,73022000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,114629000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,798000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,194068000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,,totalassets,Total Assets,=,debit,usd,365083000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11171000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12265000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,177000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,4381000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3692000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,425000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32111000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2783000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2995000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,300846000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,306624000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,338735000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,127208000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-151740000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-4018000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,54434000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,464000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,26348000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,26348000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,26348000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q2,,2017-06-30,2017-08-02 06:36:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,365083000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,75041000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,56113000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,24176000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,34731000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,190061000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5690000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,10698000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,73022000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,107875000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,798000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,192393000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,,totalassets,Total Assets,=,debit,usd,388144000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6245000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12239000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,319000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,9666000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,5821000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,2888000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,37178000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2625000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,7345000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,301362000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,311332000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,348510000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,130101000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-141372000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-4018000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,54457000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,466000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,39634000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,39634000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,39634000.0
Sucampo Pharmaceuticals Inc,SCMP,549300YPLK5FSJFMAH24,0001365216,2017.0,Q3,,2017-09-30,2017-11-01 06:35:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,388144000.0
